Caroline Caramella
0000-0003-1517-2510
Publication & Citation Trends
Most Cited Works
Publications
293 total
Circulating T-cell Immunosenescence in Patients with Advanced Non–small Cell Lung Cancer Treated with Single-agent PD-1/PD-L1 Inhibitors or Platinum-based Chemotherapy PDF
Cited by 152
OpenAlex
Outcome of Patients with Non–Small Cell Lung Cancer and Brain Metastases Treated with Checkpoint Inhibitors PDF
Cited by 239
OpenAlex
Impact of Baseline Steroids on Efficacy of Programmed Cell Death-1 and Programmed Death-Ligand 1 Blockade in Patients With Non–Small-Cell Lung Cancer PDF
Cited by 1,036
OpenAlex
Hyperprogressive Disease in Patients With Advanced Non–Small Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors or With Single-Agent Chemotherapy PDF
Cited by 728
OpenAlex
Long-Term Survival in Patients Responding to Anti–PD-1/PD-L1 Therapy and Disease Outcome upon Treatment Discontinuation
Cited by 141
OpenAlex
iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics PDF
Cited by 2,348
OpenAlex
Patterns of responses in metastatic NSCLC during PD-1 or PDL-1 inhibitor therapy: Comparison of RECIST 1.1, irRECIST and iRECIST criteria
Cited by 346
OpenAlex
Research Topics
Cancer Immunotherapy and Biomarkers
(104)
Lung Cancer Treatments and Mutations
(78)
Lung Cancer Research Studies
(46)
Immunotherapy and Immune Responses
(45)
Cancer Genomics and Diagnostics
(39)
Frequent Co-Authors
Affiliations
Université Paris-Sud
United States Nuclear Regulatory Commission
Centre National de la Recherche Scientifique
Inserm
Université Paris Cité